APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation: Response from original authors Toulon et al

J Thromb Haemost. 2021 Aug;19(8):2090-2091. doi: 10.1111/jth.15350.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants* / adverse effects
  • Heparin* / adverse effects
  • Heparin, Low-Molecular-Weight
  • Humans
  • Indicators and Reagents

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Indicators and Reagents
  • Heparin